References
- ReidIRMillerPLylesKComparison of a single infusion of zoledronic acid with risedronate for Paget’s diseaseN Engl J Med2005353989890816135834
- KaramRCammJMcClungMYearly zoledronic acid in postmenopausal osteoporosisN Engl J Med2007357771271317703529
- ChenTBerensonJVescioRPharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastasesJ Clin Pharmacol200242111228123612412821
- BlackDMDelmasPDEastellROnce-yearly zoledronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
- TanYLSimsJCheeSPBilateral uveitis secondary to bisphosphonate therapyOphthalmologica2009223321521619221448
- MooreMMBeithJMAcute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancerMed J Aust2008188637037118341464
- El SaghirNSOtrockZKBleikJHUnilateral anterior uveitis complicating zoledronic acid therapy in breast cancerBMC Cancer2005515616332258
- FraunfelderFWFraunfelderFTJensvoldBScleritis and other ocular side effects associated with pamidronate disodiumAm J Ophthalmol2003135221922212566027
- FraunfelderFWRosenbaumJTDrug-induced uveitis incidence, prevention and treatmentDrug Saf19971731972079306054
- StackRTarrKDrug-induced optic neuritis and uveitis secondary to bisphosphonatesN Z Med J20061191230U188816532052
- FiettaPManganelliPLodigianiLClodronate induced uveitisAnn Rheum Dis200362437812634250
- SautyAPecherstorferMZimmer-RothIInterleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancyBone19961821331398833207
- BendersonDKarakunnelJKathuriaSBadrosAScleritis complicating zoledronic acid infusionClin Lymphoma Myeloma20067214514717026827
- Asensio SánchezVMBotella OltraGCarrascoEBiphosphonates and intraocular inflammationArch Soc Esp Oftalmol2004792858714988788